Unim Pharmalab Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.38 M
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.46 Cr
- Satisfied Charges ₹ 6.00 M
- Revenue Growth 56.91%
- Profit Growth 753.94%
- Ebitda 46.28%
- Net Worth 27.82%
- Total Assets 39.35%
About Unim Pharmalab
Unim Pharmalab Pvt Ltd (UPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 06 September 1994 and has a history of 30 years and five months. Its registered office is in Sabarkantha, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.38 M.
The company currently has active open charges totaling ₹5.46 Cr. The company has closed loans amounting to ₹6.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mohmedyusuf Sabugar, Mohmadsakir Sabugar, and Mohammadzuber Sabugar serve as directors at the Company.
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1994PTC022962
- Company No.
022962
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Unim Pharmalab?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohmedyusuf Sabugar  | Director | 06-Sep-1994 | Current |
| Mohmadsakir Sabugar | Director | 27-May-2019 | Current |
| Mohammadzuber Sabugar | Director | 27-May-2019 | Current |
Financial Performance of Unim Pharmalab.
Unim Pharmalab Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 56.91% increase. The company also saw a substantial improvement in profitability, with a 753.94% increase in profit. The company's net worth Soared by an impressive increase of 27.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unim Pharmalab?
Unlock access to Unim Pharmalab's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Unim Foods Private LimitedMohmedyusuf Sabugar, Mohmadsakir Sabugar and 1 more are mutual person
Charges (Loans)
₹54.65 M
₹6.00 M
Charges Breakdown by Lending Institutions
- Others : 4.90 Cr
- Hdfc Bank Limited : 0.56 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2024 | Hdfc Bank Limited | ₹5.65 M | Open |
| 09 Feb 2023 | Others | ₹4.90 Cr | Open |
| 29 Jan 2013 | The Sarvodaya Nagrik Sahkari Bank Ltd. | ₹6.00 M | Satisfied |
How Many Employees Work at Unim Pharmalab?
Unim Pharmalab has a workforce of 35 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unim Pharmalab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unim Pharmalab's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
